Suven Life Sciences · NSE: SUVEN · BSE: 530239
Q1 FY19 results · Apr–Jun 2018
Suven Life Sciences reported revenue from operations of ₹191.66 crore and net profit of ₹38.84 crore for Q1 FY19 (Apr–Jun 2018), on a standalone basis.
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 191.66 | — | — | — | — |
| Other income | 8.13 | — | — | — | — |
| Total income | 199.79 | — | — | — | — |
| Profit before tax | 59.78 | — | — | — | — |
| Net profit for the period | 38.84 | — | — | — | — |
| EPS, basic (₹) | 3.05 | — | — | — | — |
| Net margin (%) | 20.3 | — | — |
Standalone
- Filed with BSE
- 20 Aug 2018, 17:19 IST
- Board meeting
- 14 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE